Ugwumba Chidozie 的 Form 4 申報
Clene Inc.（CLNN），2026/8/6 申報
- 申報編號
- 0001835544-26-000022
- 申報時間
- 2026/8/6 13:32 ET
- 交易日
- 2026/7/17
- 申報延遲
- 20 天遲報
- 10b5-1 計畫
- 沒有勾選
這份申報列了 2 筆衍生性交易。交易後 20 天才申報，超過 2 個營業日的期限。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Ugwumba ChidozieCIK 0001835544 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
這份申報沒有這一類的交易。
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F3
The Reporting Person was deemed to beneficially own the Warrants indirectly through SymBiosis II LLC by virtue of voting and investment power over the Fund's holdings. Effective July 17, 2026, such power was transferred to a different, unaffiliated third party manager, and the Reporting Person ceased to beneficially own the Warrants reported herein. No consideration was paid or received.
表 II 有 2 筆交易的價格引用這則附註。
備註
The response above noting that the Reporting Person is no longer subject to Section 16 is checked because, following the transactions reported herein, the Reporting Person no longer has any relationship to the Issuer as an owner of more than ten percent of any class of the Issuer's equity securities that would subject the Reporting Person to the reporting requirements of Section 16 of the Securities Exchange Act of 1934 with respect to the Issuer.